comparemela.com

Page 3 - Simon Agwale News Today : Breaking News, Live Updates & Top Stories | Vimarsana

What Nigeria Stands To Benefit From Our Local Vaccine Manufacturing Initiatives

What Nigeria Stands To Benefit From Our Local Vaccine Manufacturing Initiatives
thenigerianvoice.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thenigerianvoice.com Daily Mail and Mail on Sunday newspapers.

Merck Collaborates with Innovative Biotech to Support Establishment of First Vaccine Production Facility in Nigeria

/PRNewswire/ Merck, a leading science and technology company, today announced that it has signed an agreement with biotechnology company Innovative Biotech.

How to contain Omicron, future COVID-19 variants of concern

It is feared that the new COVID-19 variant B.1.1.529 (Omicron) might have been circulating in Nigeria since last week as two passengers from here, on Sunday, November 28, tested positive to the virus on arrival in Ottawa, Canada.

Race for new COVID-19 treatments as vaccine efficacy wanes in six months | The Guardian Nigeria News - Nigeria and World News — Features — The Guardian Nigeria News – Nigeria and World News

Anxiety as COVID-19 deaths in Africa surge, deadly variant spreads | The Guardian Nigeria News - Nigeria and World News — Features — The Guardian Nigeria News – Nigeria and World News

• Spike Driven By Public Fatigue With Key Health Measures Experts • Hospital Admissions Increase Rapidly The confirmation of the highly transmissible and deadly Delta variant of COVID-19 in Lagos and Oyo States, last Monday, and spike in pandemic-induced deaths in Africa, has heightened concerns of resurgence of infections in the country. Experts, who spoke to The Guardian, yesterday, said the surge in new infections and deaths was driven by public fatigue with key health measures and increased spread of variants. They also warned that the situation has led to rapid increase in hospital admissions even as countries face shortages in oxygen and intensive care beds.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.